Durability of protective antibody titres is not enhanced by a two-dose schedule of an ASO3-adjuvanted pandemic H1N1 influenza vaccine in adult HIV-1-infected patients
Author(s):
Bickel, M.; Lais, C.; Wieters, I.; Kroon, F.P.; Doerr, H.W.; Herrmann, E.; Brodt, H.R.; Jung, O.; Allwinn, R.; Stephan, C.
Published
2014
Publication type
Article / Letter to editor
HIVH1N1adjuvantedpandemicdurability
Date issued
2014-09-30
Language
English
Is part of
Scandinavian Journal of Infectious Diseases (2014), Vol. 46, no. 9, p. 656-659
